click below
click below
Normal Size Small Size show me how
MOA
| Drug | MOA |
|---|---|
| Carbamazepine | Blocks firing of action potentials presynapticallyq |
| Aripiprazole | Partial D2 and D3 receptor agonist |
| Lurasidone | High affinity D2, 5-HT2, and 5-HT7 receptors |
| Olanzipine | Potent D2 and 5HT2 receptor antagonist |
| Quetiapine | H1 antagonist, 5HT1A and 5HT2 |
| Risperidone | Potent 5HT2 antagonist weak D2 |
| Ziprasidone | 5HT2A to D2 blockade |
| Butalbital APAP Caffeine | Inhibits phosphodiesterase, GABA receptors |
| Phenytoin | Inhibits synaptic post tetanic potentiation |
| Divalproex | Inhibits GABA metabolism |
| Lacosamide | Stabilizes hyperexcitable neuronal membranes |
| Clobazam | Potentiation due to binding in Benzo site of GABA-A |
| Levetiracetam | facilitation of GABA-ergic inhibitory transmission |
| Topiramate | Antagonizes the AMPA/kainite glutamate receptor |
| Oxcarbazepine | Blockade of VG sodium channel and inhibition of repetitive neuronal firing |
| Phenobarbital | Depress monosynaptic responses in the CNS |
| Lamotrigine | Inhibits VG sodium channels = reduces the release of glutamate and aspartate |
| Lithium | Alters cation transport across cell membrane |
| Benztropine | Inhibits cholinergic and histamine receptors |
| Carbidopa Levodopa | Increases levodopa at the BBB, crosses BBB and is converted to dopamine |
| Pramipexole | Nonergot-derived dopamine subtype-selective agonist D2 and D3 |
| Ropinirole | Nonergloine dopamine agonist for D2 |
| Donepezil | Inhibits AChE = enhances acetylcholine |
| Memantine | Uncompetitive NMDA receptor antagonist |
| Rizatriptan | Selective agonist for serotonin in cranial arteries, vasoconstriction |